Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder

• Published in: The Journal of urology Vol. 163; no. 3; p. 993
• Main Authors: Wang, X C, Saban, R, Kaysen, J H, Saban, M R, Allen, P L, Benes, E N, Hammond, T G
• Format: Journal Article
• Language: English
• Published: United States 01.03.2000
• Subjects: Administration, Intravesical; Animals; Cystitis - etiology; Cystitis - pathology; DNA-Binding Proteins - analysis; Female; Flow Cytometry; Lipopolysaccharides - administration & dosage; Mice; Mice, Inbred BALB C; NF-kappa B - analysis; NF-kappa B - metabolism; NF-kappa B - physiology; Receptors, Neurokinin-1 - analysis; Transcription Factor RelA
• ISSN: 0022-5347
• DOI: 10.1016/S0022-5347(05)67870-6

The proteins which constitute the final common pathway linking receptors on cell surfaces to the inflammatory cascade have recently been identified and cloned. Central to activation of this inflammatory cascade is translocation from cytosol to nucleus of the nuclear transcription factor known as nuclear factor-kappa B (NF-kappaB). The purpose of this study was to determine whether NF-kappaB cascade plays a role in lipopolysaccharide (LPS)-induced inflammation of the mouse urinary bladder. Bladder inflammation was induced in anesthetized mice by intravesical instillation of lipopolysaccharide (LPS) and quantified by morphometric analysis. The NK-1 receptors for substance P were quantified by flow cytometry. LPS-induced degradation of inhibitory IkappaB subunit was quantified by Western blotting analysis and translocation of NF-kappaB protein from cytosol to the nucleus was determined by confocal microscopy and Western blotting analysis. In addition, we determine the effect of lactacystin, a proteosome inhibitor, on LPS-induced IkappaB degradation and NF-kappaB translocation, NK-1 receptor fluorescence intensity, and bladder inflammation. LPS instillation into the mouse bladder resulted in time dependent loss of the inhibitory IkappaB subunit of the NF-kappaB protein complex. IkappaB cleavage was followed by translocation of NF-kappaB from the cytosol to the nucleus. This was associated with increased expression of an NF-kappaB dependent inflammatory component, the NK-1 receptor. Pretreatment of mouse bladders with the NF-kappaB inhibitor, lactacystin, prevented cleavage of IkappaB in a dose-dependent manner. Lactacystin prevented increases in the NF-kappaB dependent inflammatory cascade components such as the NK-1 receptor. At the whole tissue level, the marked inflammatory infiltrate and mucosal breakdown associated with LPS administration was completely abolished by lactacystin. NF-kappaB mediates many features of urinary bladder inflammation induced by LPS. The NF-kappaB cascade is an important target for anti-inflammatory management of cystitis.